Lawsuits from victims of faulty Bard IVC filters have been centralized in a newly formed multidistrict litigation (MDL) in Arizona. This will allow recipients of the Bard IVC to join together in a common lawsuit that will challenge the devices manufacturer for allegedly designing and distributing a faulty product that carried potentially life-threatening side effects. In the wake of the Arizona Bard IVC MDL ruling, thousands of potential plaintiffs may be able to pursue their legal claim in the state.
Bard IVC Filter Lawsuits Allege Life-Threatening Defects
The Bard IVC Filter was designed and marketed as a device that would prevent deadly blood clots in the lungs. Inferior vena cava (IVC) devices are surgically implanted into a patient’s veins in order to keep blood clots from moving into the lungs, and Bard’s IVC devices were used heavily in the early 2000’s by surgeons across the country. Over the last ten years, the FDA has received complaints that the Bard IVC Filters created complications that punctured organs and blood vessels, or moved the filters to another part of the body where they could not prevent deadly blood clots.